iodoacetamide has been researched along with Metabolic Syndrome in 1 studies
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kowalczyk, E | 1 |
| Kowalski, J | 1 |
| Błaszczyk, J | 1 |
| Gwoździński, Ł | 1 |
| Ciećwierz, J | 1 |
| Sienkiewicz, M | 1 |
1 other study available for iodoacetamide and Metabolic Syndrome
| Article | Year |
|---|---|
Estimation of cell membrane properties and erythrocyte red-ox balance in patients with metabolic syndrome.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Erythrocyte Membrane; Female; Humans; Iodoacetamide; | 2012 |